Scope Fluidics SA GPW:SCP:
BACTEROMIC SIGNS AGREEMENT WITH COMAC MEDICAL FOR CLINICAL TRIALS OF BACTEROMIC PBC PANEL
ESTIMATED COST OF CLINICAL TRIALS NOT TO EXCEED EUR 1 MILLION
IVDR CERTIFICATION FOR BACTEROMIC PBC PANEL EXPECTED IN 2027
Scope Fluidics' Bacteromic Signs Agreement With Comac Medical For Clinical Trials Of Bacteromic PBC Panel
Earlier from Scope Fluidics Sa
- Scope Fluidics Says Bacteromic Buys New Location For Semi-Automated Bacteromic Panel Production Line
- Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
- Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
- Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials